Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Evita’s Mifepristone Approval Reignites Controversy Over Abortion Pill
FDA Nod For Generic Becomes Lightning Rod In US Abortion Debate
Oct 03 2025
•
By
Dave Wallace
RFK Jr has indicated that mifepristone is in line for an imminent safety review
(Shutterstock)
More from Generics
More from Products